Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Nov;83(22):8749-53.
doi: 10.1073/pnas.83.22.8749.

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint

E R Pettipher et al. Proc Natl Acad Sci U S A. 1986 Nov.

Abstract

Interleukin 1 (IL-1) is a polypeptide released by activated macrophages and is thought to be a key mediator of host responses to infection and inflammation. The availability of highly purified and recombinant material has now permitted the evaluation of IL-1 as a mediator of chronic inflammatory processes in vivo. We have demonstrated that intraarticular injection of IL-1 into rabbit knee joints induces the accumulation of polymorphonuclear and mononuclear leukocytes in the joint space and the loss of proteoglycan from the articular cartilage. The effects on cartilage could not be explained solely by the presence of leukocytes, since injections of endotoxin also stimulated leukocyte accumulation in the joint but had no effect on proteoglycan loss. Responses to IL-1 were not associated with increased production of the icosanoids prostaglandin E2 or leukotriene B4 and were not reduced by an inhibitor of their synthesis. The pattern of leukocyte infiltration and cartilage breakdown 24 hr after IL-1 injection was similar to that seen in animals with antigen-induced arthritis of 1 week's duration. These observations support the hypothesis that IL-1 acts directly to mediate the erosive processes of chronic arthritis.

PubMed Disclaimer

References

    1. Biochem J. 1984 Dec 1;224(2):461-6 - PubMed
    1. Clin Exp Immunol. 1984 Feb;55(2):295-302 - PubMed
    1. J Immunol Methods. 1985 Oct 24;83(1):1-27 - PubMed
    1. J Immunol Methods. 1985 Oct 24;83(1):201-7 - PubMed
    1. Biomed Pharmacother. 1986;40(2):45-9 - PubMed

LinkOut - more resources